Delhi, First Published Jul 3, 2021, 9:40 AM IST
The company claims that Bharat Biotech’s covaxin is 77.8 per cent effective against the corona virus. Vaccine maker Bharat Biotech has released the details of the third phase of Kovacs testing. The Hyderabad-based company on Friday released the third phase of testing on the effectiveness of the vaccine.
The company claims that the vaccine is 65.2 percent effective against the Covid Delta variant. The company claims that the vaccine is completely safe and provides irreplaceable immunity.
The Delta variety is currently the leading cause of disease transmission in India. The company claims that the effectiveness of Kovacs is 77.8 percent against common symptoms and 93.4 percent against severe symptoms.
The study found that those who received the two-dose vaccine achieved 98 percent safety from death
In this time of the second outbreak of the Kovid epidemic, Asianet News urges everyone to wear masks, sanitize, maintain social distance and be vaccinated. Together we can defeat the epidemic. #BreakTheChain #ANCares #IndiaFightsCorona
Last Updated Jul 3, 2021, 9:44 AM IST